United Kingdom· GB-APID-45396711000001104
Relugolix 120mg tablets
A relugolix product containing relugolix, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Relugolix is registered in 15 of 19 countries.
Countries holding a registration under ATC L02BX04 (relugolix), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Relugolix · ATC L02BX04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of relugolix costs, country by country.
Normalised to the WHO defined daily dose (0.12 g), the median price runs from $3.40 in France to $9.83 in Italy — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Relugolix · price per daily dose (0.12 g)
USD · FX 28 Sept 2026
- IT Italy$9.83
- ES Spain$7.69
- CH Switzerland$6.03
- FR France$3.40
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Relugolix
- Manufacturer
- A A H Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- L02BX04
- ATC class
- Relugolix
- Defined daily dose
- 0.12 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
168 interactions on record for relugolix.
Graded by severity as the source publishes them — 52 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Relugolix · interactions on record
168 records
- 52 severe
- 101 moderate
- 15 minor
Most severe, free to view
- PapaverineA03AD01severe
- DolasetronA04AA04severe
- RolapitantA04AD14severe
- FidaxomicinA07AA12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Relugolix in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaORGOVYXSUMITOMO PHARMA SWITZERLAND GMBH
- CzechiaORGOVYXAccord Healthcare S.L.U., Barcelona
- FinlandOrgovyxAccord Healthcare S.L.U.
- NorwayOrgovyxAccord Healthcare S.L.U.
- BelgiumOrgovyx 120 mgAccord Healthcare
- IrelandOrgovyx 120 mg film-coated tabletsAccord Healthcare S.L.U.
- IcelandOrgovyxAccord Healthcare S.L.U.
- ItalyORGOVYX*30 cpr rivestite 120 mg flaconeACCORD HEALTHCARE SLU
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Orgovyx
- Liechtenstein · Orgovyx
- Norway · Orgovyx
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f86ed5b7-72c4-4312-9b6d-21da7c09c2ae GET /v1/drugs/f86ed5b7-72c4-4312-9b6d-21da7c09c2ae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45396711000001104",
"desc": "Relugolix 120mg tablets (A A H Pharmaceuticals Ltd)",
"form": "Oral tablet",
"vpid": "41462611000001101",
"source": "dmd",
"vtm_id": "1144511002",
"strength": "120 mg",
"substance": "Relugolix",
"ingredient": "Relugolix",
"supplier_code": "3144701000001104"
}See everything about relugolix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.